Home › NCT07301905

Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI

Culturally Targeted Messaging and Parental Receptivity to the Human Papillomavirus Vaccine

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Identify as Black/African American or White/Caucasian
* Have at least one daughter who is between 8-17 years of age, who is not currently pregnant, and who has not received any doses of the HPV vaccine

Exclusion Criteria:

* N/A

About the study

The goal of this clinical trial is to learn if culturally targeted messaging about the human papillomavirus (HPV) increases receptivity to the HPV vaccine among African American parents of vaccine-eligible daughters. The main question it aims to answer is:

• Does culturally targeted messaging increase African American parents' intentions to vaccinate their daughter against HPV?

Research will compare culturally targeted messaging to general, educational messaging and no messaging.

Participants will:

* View culturally targeted messages, education-only messages, or no messages about the HPV vaccine * Report their intentions to vaccinate their daughter against HPV * Report whether they have initiated HPV vaccination for their daughter six months later

What is being tested

• General HPV Vaccine Health Messaging (behavioral)
• Culturally Targeted HPV Vaccine Health Messaging (behavioral)

Sponsor: Michigan State University · Participants: 265 · Started: Nov 17, 2024

Contact the study team

• Olivia Aspiras, PhD · Phone: 810-600-9181

Official record on ClinicalTrials.gov — NCT07301905

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.